<DOC>
	<DOCNO>NCT00882219</DOCNO>
	<brief_summary>Interventional , prospective , non-randomized , non-comparative , open multicentric study patient everolimus-eluting stent `` Xience V® `` implant treatment restenosis non-coated metallic stent ( BMS in-stent restenosis ) 2 year clinical follow-up period .</brief_summary>
	<brief_title>Clinical Evaluation Patients With Everolimus-eluting Stent Xience V® Implanted Treatment Restenosis Non-coated Metallic Stent ( BMS In-stent Restenosis ) During 2 Year Clinical Follow-up Period</brief_title>
	<detailed_description />
	<mesh_term>Coronary Restenosis</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Patients 18 year age old Patients affiliate social security equivalent regimen Patients agree participate study ( Patient sign informed consent ) Patients evidence myocardial ischemia ( stable unstable angina , silent ischemia , positive functional exploration reversible modification ECG consistent ischemia ) . Patient acceptable candidate CABG surgery Patient agree undergo protocol schedule followup examination . Patients tolerate association Aspirin ( dose 75 160 mg/day ) Clopidogrel 75 mg/day least 6 month Angiographic inclusion criterion : Patient de novo sole instent restenosis ( focal , diffuse proliferative ) noncoated metallic stent without coronary lesion . Patient target reference vessel diameter 2.5 4 mm visual estimate Patient target lesion ≤ 22mm visual estimate Patient target lesion artery visual estimate restenosis 50 99 % TIMI flow grade &gt; 1 Patient multiple lesion , lesion treat success Patient emergency Patient pregnant Patient nursing Patient unable give inform consent personally . Patient myocardial infarction within previous 72 hour . Patient limit life expectancy ( less 1 year postinclusion ) Patient unstable arrhythmia Patient leave ventricular ejection fraction ( LVEF ) lesser 30 % Patient receiver cardiac organ transplantation candidate organ transplant Patient receive schedule receive chemo radio therapy within 30 day prior protocolrelated procedure . Patient treat immunosuppressive know immunodepressive autoimmune pathology Patient receive chronically anticoagulant therapy INR great 2.5 Patient know hypersensitivity contraindication antiplatelet drug , everolimus , heparin , chromium cobalt alloy , nickel , tungsten , acrylic fluoro polymer sensitivity angiographic contrast agent . Patient plan elective surgery require interruption discontinuation antiplatelet therapy . Patient platelet count &lt; 100 000/ mm3 &gt; 700 000mm3 ; WBC count &lt; 3 000/mm3 know suspect liver disease Patient severe renal insufficiency ( creatinine clearance rate &lt; 30 ml/min ) , dialysis Patient history coagulopathy refuse blood transfusion Patient stroke/cerebrovascular accident transient cerebrovascular ischemia precede 6 month Patient urinary gastrointestinal bleed precede 6 month Patient know serious medical illness know history substance abuse ( alcohol , drug ) might result noncompliance investigational plan , interfere result diminish life expectancy less year . Patient enrol interventional study another medical device drug Angiographic exclusion criterion Patient instent restenosis locate leave main coronary bypass Patient lesion instent restenosis locate bifurcation include lateral branch diameter &gt; 1.5mm Patient target vessel totally occluded Patient lesion restenosis previously treat another device ( exception balloontipped catheter ) cut balloon , atherectomy , laser , brachytherapy another medicate stent . Patient thrombus target vessel Patient aortoostiale lesion Patient previous failure multiple lesion treat angioplasty .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Drug elute stent</keyword>
	<keyword>Stents</keyword>
	<keyword>Angioplasty</keyword>
	<keyword>Chronic coronary occlusion</keyword>
	<keyword>Stent thrombosis</keyword>
	<keyword>Vascular disease</keyword>
	<keyword>Myocardial ischemia</keyword>
	<keyword>Coronary artery stenosis</keyword>
	<keyword>Coronary Disease</keyword>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>Coronary Restenosis</keyword>
</DOC>